VectivBio (VECT) News Today $16.85 0.00 (0.00%) (As of 12/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period CDR-Life Appoints Sarah Holland, PhD, as Chief Business OfficerDecember 5, 2024 | finance.yahoo.comGraft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsightSeptember 23, 2024 | finance.yahoo.comCompare with VectivBio Holding AG (VECT)May 29, 2024 | msn.comenGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of DirectorsMay 15, 2024 | finance.yahoo.comVicore Pharma Holding: Vicore Expands and Strengthens its Board of DirectorsMay 14, 2024 | finanznachrichten.deVicore Expands and Strengthens its Board of DirectorsMay 14, 2024 | finance.yahoo.comShort Bowel Syndrome Market by 2032: Forecast Report Estimates Significant GrowthApril 5, 2024 | uk.finance.yahoo.comRegency Capital Management Inc. DE Has $8.59 Million Position in VectivBio Holding AG (NASDAQ:VECT)Regency Capital Management Inc. DE increased its stake in VectivBio Holding AG (NASDAQ:VECT - Free Report) by 1,600.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 510,000 shares of the company's stock after purchasing an additional 480,000 shApril 3, 2024 | marketbeat.comPipeline moves: Approval prospects for SBS candidate rise after Phase III trial meets endpointsMarch 18, 2024 | msn.comUPDATE 3-Ironwood's bowel disease drug meets main goal of late-stage studyMarch 1, 2024 | msn.comIronwood's bowel disease treatment meets main goal in late-stage trialFebruary 29, 2024 | reuters.comWhy Is Gastrointestinal Healthcare Focused Ironwood Pharmaceuticals Stock Sinking On Thursday?February 29, 2024 | benzinga.comOnly two sleeps left until February 31!February 29, 2024 | ft.comShort Bowel Syndrome Market Size and Share is Anticipated to Surge During the Study Period (2020–2034) | DelveInsightFebruary 22, 2024 | finance.yahoo.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2023 Earnings Call TranscriptFebruary 16, 2024 | finance.yahoo.comIronwood seals the deal on VectivBio mergerDecember 13, 2023 | msn.comIronwood Announces the Completion of Squeeze-Out Merger With VectivBioDecember 12, 2023 | finance.yahoo.comReverb Therapeutics Debuts Its Amplifier™ Platform for Redirecting Endogenous CytokinesNovember 15, 2023 | tmcnet.comIronwood's (IRWD) Q3 Earnings Miss Mark, Linzess Volume RisesNovember 10, 2023 | msn.comAkash Tewari’s Buy Rating on Ironwood Pharma: Linzess Floor Trading and Apraglutide’s Promising FutureNovember 10, 2023 | markets.businessinsider.comHold Rating for Ironwood Pharma Driven by Stable Linzess Revenue and Anticipated Apraglutide Data, Despite T Cell Data DelayNovember 10, 2023 | markets.businessinsider.comIronwood Pharmaceuticals Inc (IRWD) Reports Growth in LINZESS Sales and Maintains Full Year GuidanceNovember 9, 2023 | finance.yahoo.comIronwood Pharmaceuticals: The Right Play NowOctober 27, 2023 | msn.comIronwood Pharmaceuticals’ Apraglutide Shows Promising Results in STARS Nutrition and VectivBio Trials: An Emphasis on Jason Butler’s Buy RatingOctober 16, 2023 | markets.businessinsider.comWhy Is Ironwood (IRWD) Down 9.6% Since Last Earnings Report?September 7, 2023 | finance.yahoo.comEQS-News: Abivax appoints Patrick Malloy as Senior Vice President Investor RelationsAugust 23, 2023 | markets.businessinsider.comAbivax Appoints Patrick Malloy as Senior Vice President Investor RelationsAugust 23, 2023 | finance.yahoo.comIronwood's (IRWD) Reports Q2 Loss, Linzess Volume RisesAugust 9, 2023 | msn.comQ2 2023 Ironwood Pharmaceuticals Inc Earnings CallAugust 9, 2023 | uk.finance.yahoo.comInstrument Name Vectivbio Holding Ag Instrument Symbol (VECT-Q)July 16, 2023 | theglobeandmail.comIronwood and VectivBio Announce the Completion of the Tender Offer for VectivBio SharesJune 29, 2023 | finance.yahoo.comVectivBio AG: VectivBio Extraordinary General Meeting of Shareholders Approved All ProposalsJune 27, 2023 | finanznachrichten.deVectivBio Extraordinary General Meeting of Shareholders Approved All ProposalsJune 26, 2023 | finance.yahoo.comIronwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of VectivBioJune 16, 2023 | finance.yahoo.comMoore Kuehn Encourages VECT, EMBK, BACK, and RADI Investors to Contact Law FirmMay 31, 2023 | benzinga.comVECTIVBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of VectivBio Holding AG ...May 25, 2023 | businesswire.comPiper Sandler Downgrades VectivBio Holding (VECT)May 24, 2023 | msn.comWhat 4 Analyst Ratings Have To Say About VectivBio HoldingMay 23, 2023 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Rocket Pharmaceuticals (RCKT) and VectivBio Holding (VECT)May 23, 2023 | markets.businessinsider.comIronwood (IRWD) to Acquire VectivBio for $1B, Stock Up 3.6%May 23, 2023 | finance.yahoo.comCredit Suisse Downgrades VectivBio Holding (VECT)May 23, 2023 | msn.comSVB Leerink Downgrades VectivBio Holding (VECT)May 23, 2023 | msn.comIronwood bulks up on digestive therapies with $1.15 billion VectivBio buyMay 23, 2023 | msn.comVectivBio Stock Catapults 39% After Ironwood Agrees To Buy It For $1 BillionMay 22, 2023 | finance.yahoo.comThinking about buying stock in Palantir Technologies, DraftKings, Micron Technology, Rain Oncology, or VectivBio?May 22, 2023 | benzinga.comVectivBio Stock Catapults 38% After Ironwood Agrees To Buy It For $1 BillionMay 22, 2023 | finance.yahoo.comWhy Shares of VectivBio Holding Are Up TodayMay 22, 2023 | finance.yahoo.comIronwood Pharma to acquire VectivBio for $1.15 billionMay 22, 2023 | news.yahoo.comIronwood Pharmaceuticals to acquire Swiss biotech VectivBio in deal valued at about $1 billionMay 22, 2023 | msn.comIronwood Pharma To Acquire VectivBio For $17/Shr In All-cash DealMay 22, 2023 | markets.businessinsider.com Get VectivBio News Delivered to You Automatically Sign up to receive the latest news and ratings for VECT and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now VECT Media Mentions By Week VECT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VECT News Sentiment▼0.000.60▲Average Medical News Sentiment VECT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VECT Articles This Week▼00▲VECT Articles Average Week Get VectivBio News Delivered to You Automatically Sign up to receive the latest news and ratings for VECT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NAMS News IDYA News CNTA News RXRX News IBRX News APGE News WVE News AKRO News MIRM News TARS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VECT) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VectivBio Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share VectivBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VECT Stock Alerts